您当前的位置：
首页 >
文章列表页 >
Research progress on the role of NF-κB signaling pathway in drug resistance mechanisms of pancreatic cancer
Medical Journal of Chinese People′s Liberation Army   Vol. 50, Issue 6, Pages: 665-671(2025)
Special Issue on Mechanisms, Targeting, and Treatment Strategies of Tumor Immunotherapy | 更新时间：2025-07-10

    • Research progress on the role of NF-κB signaling pathway in drug resistance mechanisms of pancreatic cancer

    • “According to the latest research, the 5-year survival rate of pancreatic cancer patients is low, and the NF - κ B signaling pathway is closely related to tumor drug resistance, providing new ideas for the treatment of pancreatic cancer.”

    • DOI：10.11855/j.issn.0577-7402.1474.2025.0327    

      CLC： R735.9

    • Received：24 September 2024，

      Accepted：11 December 2024，

      Published：28 June 2025

    移动端阅览

  • Shu Ya-Ting,Shi Jing-Wen,Lei Fan,et al.Research progress on the role of NF-κB signaling pathway in drug resistance mechanisms of pancreatic cancer[J].Medical Journal of Chinese People′s Liberation Army,2025,50(06):665-671. DOI： 10.11855/j.issn.0577-7402.1474.2025.0327.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Effect of downregulating Hsa-circ-0101216 expression on gemcitabine chemoresistance in pancreatic cancer and its mechanism
Research progress of an immune checkpoint molecule VISTA in hematological tumors
Research progress of neoantigens in tumor immunotherapy
Advances in the study of neoantigen pulsed dendritic cell vaccines in tumor immunotherapy
Research progress on MAGE-A4 in tumor diagnosis and immunotherapy

Related Author

Liu Hai-Chao
Liu Shao-Peng
Yan Hong-Xian
Bai Ming-Hui
Zhang Ji-Xiang
Li Ying-Bo
Wang Chuang
Zou Kai

Related Institution

Hepatobiliary Pancreatic Surgery Department of Luoyang Central Hospital
Department of Hematology, the Second Hospital of Lanzhou University
Department of Research, the Second Affiliated Hospital of Xi`an Medical University
Department of Tumor Surgery, the Second Hospital of Lanzhou University
Gansu Provincial Key Laboratory of Gastrointestinal Tumors
0